<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101701004</journal-id>
<journal-id journal-id-type="pubmed-jr-id">46235</journal-id>
<journal-id journal-id-type="nlm-ta">Birth Defects Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Birth Defects Res</journal-id>
<journal-title-group>
<journal-title>Birth defects research</journal-title>
</journal-title-group>
<issn pub-type="epub">2472-1727</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28635121</article-id>
<article-id pub-id-type="pmc">5555794</article-id>
<article-id pub-id-type="doi">10.1002/bdr2.1052</article-id>
<article-id pub-id-type="manuscript">NIHMS870997</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Exposure to sodium valproate during pregnancy: Facial features and signs of autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Stadelmaier</surname>
<given-names>Rachel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nasri</surname>
<given-names>Hanah</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deutsch</surname>
<given-names>Curtis K.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bauman</surname>
<given-names>Margaret</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hunt</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stodgell</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adams</surname>
<given-names>Jane</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holmes</surname>
<given-names>Lewis B.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Albert Einstein College of Medicine, Bronx, NY</aff>
<aff id="A2">
<label>2</label>The Medical Genetics Unit, MassGeneral Hospital <italic>for</italic> Children, University of Massachusetts Medical School, Worcester, MA</aff>
<aff id="A3">
<label>3</label>Department of Pediatrics, Harvard Medical School, University of Massachusetts Medical School, Worcester, MA</aff>
<aff id="A4">
<label>4</label>The Psychobiology Program at the Eunice Kennedy Shriver Center and Departments of Psychiatry and Pediatrics, University of Massachusetts Medical School, Worcester, MA</aff>
<aff id="A5">
<label>5</label>Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA</aff>
<aff id="A6">
<label>6</label>Hunt Consulting Associates, Chapel Hill, NC</aff>
<aff id="A7">
<label>7</label>Department of OB/GYN, University of Rochester School of Medicine &amp; Dentistry, Rochester, NY</aff>
<aff id="A8">
<label>8</label>Department of Psychology, UMass-Boston</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Rachel Stadelmaier, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461; <email>stadelma@mail.einstein.yu.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P46">Any conflict of interest disclosures: None declared</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>19</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>109</volume>
<issue>14</issue>
<fpage>1134</fpage>
<lpage>1143</lpage>
<!--elocation-id from pubmed: 10.1002/bdr2.1052-->
<abstract>
<sec id="S1">
<title>BACKGROUND</title>
<p id="P1">Valproic acid (VPA) is the most teratogenic anticonvulsant drug in clinical use today. Children exposed prenatally to VPA have previously been shown to have dysmorphic craniofacial features, identified subjectively but not by anthropometric methods. Exposure to VPA has also been associated with an increased frequency of Autism Spectrum Disorder (ASD). An increased cephalic index (the ratio of the cranial lateral width to the cranial anterior-posterior length) has been observed in children with ASD.</p>
</sec>
<sec id="S2">
<title>METHODS</title>
<p id="P2">Forty-seven children exposed to VPA during the first trimester of pregnancy were evaluated for dysmorphic facial features, identified subjectively and by measurements. Each VPA-exposed child was evaluated for ASD using the SCQ (Social Communication Questionnaire), ADI-R (Autism Diagnostic Interview-Revised) and ADOS (Autism Diagnostic Observation Schedule). The same physical examination was carried out on an unexposed comparison group of 126 children. The unexposed children also had testing for cognitive performance by WISC-III (the Wechsler Intelligence Scale for Children).</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P3">Several dysmorphic craniofacial features, including telecanthus, wide philtrum and increased length of the upper lip were identified subjectively. Anthropometric measurements documented additional findings including an increased cephalic index, decreased head circumference/height index, and increased intercanthal distance. There were no differences between the craniofacial features of VPA-exposed children with and without ASD.</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS</title>
<p id="P4">An increased frequency of dysmorphic craniofacial features was identified in children exposed to VPA during the first trimester of pregnancy. The most consistent finding was a larger cephalic index, which indicates a disproportion of increased width of the skull relative to the shortened anterior-posterior length.</p>
</sec>
</abstract>
<kwd-group>
<kwd>valproic acid</kwd>
<kwd>“valproate embryopathy”</kwd>
<kwd>cephalic index</kwd>
<kwd>Autism Spectrum Disorder</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>